| 05th week of 2018 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20180028425 | COSMETIC COMPOSITIONS OF UV FILTERS | 2018-02-01 |
| 20180028426 | USE OF COMPOSITION CONTAINING P-113 PEPTIDE IN PREPARING COSMETICS HAVING MOISTURIZING FUNCTION | 2018-02-01 |
| 20180028427 | PROCESS FOR THE PURIFICATION OF HEPARAN SULFATE AND USE THEREOF IN COSMETOLOGICAL AND DERMATOLOGICAL PREPARATIONS | 2018-02-01 |
| 20180028428 | LEAVE-IN HAIR TREATMENT COMPOSITION | 2018-02-01 |
| 20180028429 | MIXTURE OF ACTIVE INGREDIENTS FOR HAIRSTYLING COMPOSITIONS | 2018-02-01 |
| 20180028430 | COSMETIC | 2018-02-01 |
| 20180028431 | POLYMER-BASED ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF | 2018-02-01 |
| 20180028432 | LONG-WEARING, TRANSFER-RESISTANT COSMETIC COMPOSITION HAVING IMPROVED TACKINESS | 2018-02-01 |
| 20180028433 | COMPOSITION TO REDUCE THE DRYING TIME OF KERATIN FIBERS, METHOD AND USE THEREOF | 2018-02-01 |
| 20180028434 | HAIR STYLING COMPOSITION | 2018-02-01 |
| 20180028435 | AQUEOUS HAIR STYLING COMPOSITION COMPRISING HIGH AMOUNTS OF WAXES AND FATTY COMPOUNDS | 2018-02-01 |
| 20180028436 | TOPICAL FORMULATION OF HOPS EXTRACT | 2018-02-01 |
| 20180028437 | OBTAINING AN EXTRACT FROM BROWN ALGAE GAMETOPHYTES, AND USE OF SAID EXTRACT AS A COSMETIC ANTI-AGING ACTIVE PRINCIPLE | 2018-02-01 |
| 20180028438 | TOPICAL FORMULATION | 2018-02-01 |
| 20180028439 | COMBINATION THERAPY FOR COPD | 2018-02-01 |
| 20180028440 | Milrinone Composition and Method for Administering Same | 2018-02-01 |
| 20180028441 | SYSTEM FOR MANAGING INHALANT AND BREATH ANALYSIS DEVICES | 2018-02-01 |
| 20180028442 | NANOEMULSION COMPOSITIONS OF TAXOID DRUGS, AND METHODS FOR THE USE THEREOF TO TARGET CANCER CELLS AND CANCER STEM CELLS | 2018-02-01 |
| 20180028443 | USE OF BIOCOMPATIBLE MICRODROPLETS FOR THE TREATMENT OF ATHEROSCLEROSIS, HEART DISEASE AND STROKE | 2018-02-01 |
| 20180028444 | COMPOSITIONS AND METHODS OF TUMOR TREATMENT UTILIZING NANOPARTICLES | 2018-02-01 |
| 20180028445 | CNS DELIVERY OF MRNA AND USES THEREOF | 2018-02-01 |
| 20180028446 | Nanostructure Enhanced Targeting (NSET) of Inflammatory Cells | 2018-02-01 |
| 20180028447 | DEVELOPMENT OF CURCUMIN AND PIPERINE LOADED DOUBLE-LAYERED BIOPOLYMER BASED NANO DELIVERY SYSTEMS BY USING ELECTROSPRAY / COATING METHOD | 2018-02-01 |
| 20180028448 | Pharmaceutical Formulation of Racecadotril | 2018-02-01 |
| 20180028449 | Technology for the Preparation of Microparticles | 2018-02-01 |
| 20180028450 | Encased Tamper Resistant Controlled Release Dosage Forms | 2018-02-01 |
| 20180028451 | IMMEADIATE RELEASE ORAL TABLET | 2018-02-01 |
| 20180028452 | ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS | 2018-02-01 |
| 20180028453 | Methods for Controlled Release Oral Dosage of a Vitamin D Compound | 2018-02-01 |
| 20180028454 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF TO TREAT PANCREATIC ENZYME INSUFFICIENCY | 2018-02-01 |
| 20180028455 | PEPTIDE/PARTICLE DELIVERY SYSTEMS | 2018-02-01 |
| 20180028456 | DELIVERING FUNCTIONAL NUCLEIC ACIDS TO MAMMALIAN CELLS VIA BACTERIALLY-DERIVED, INTACT MINICELLS | 2018-02-01 |
| 20180028457 | Compositions and Methods for the Delivery of Therapeutics | 2018-02-01 |
| 20180028458 | COATED CHITOSAN-BASED POLYPLEX FOR DELIVERY OF NUCLEIC ACIDS | 2018-02-01 |
| 20180028459 | METHOD OF PRODUCING TRANSDERMAL ABSORPTION SHEET | 2018-02-01 |
| 20180028460 | PROCESS FOR OBTAINING A SYSTEM FOR THE CONTROLLED DELIVERY OF A BIOLOGICALLY ACTIVE SUBSTANCE AND CONTROLLED DELIVERY SYSTEM OBTAINED THEREBY | 2018-02-01 |
| 20180028461 | TRANSDERMAL DELIVERY SYSTEMS WITH PHARMACOKINETICS BIOEQUIVALENT TO ORAL DELIVERY | 2018-02-01 |
| 20180028462 | DONEPEZIL TRANSDERMAL DELIVERY SYSTEM | 2018-02-01 |
| 20180028463 | TRANSDERMAL FORMULATION AND DELIVERY METHOD OF LOW SOLUBILITY OR UNSTABLE UNIONIZED NEUTRAL DRUGS BY IN SITU SALT-TO-NEUTRAL DRUG CONVERSION OF SALT DRUG | 2018-02-01 |
| 20180028464 | ADHESIVE PATCH | 2018-02-01 |
| 20180028465 | TRANSDERMAL THERAPEUTIC SYSTEM WITH AN OVERTAPE COMPRISING TWO ADHESIVE LAYERS | 2018-02-01 |
| 20180028466 | MEMANTINE TRANSDERMAL DELIVERY SYSTEMS | 2018-02-01 |
| 20180028467 | TRANSDERMAL DELIVERY SYSTEMS WITH PHARMACOKINETICS BIOEQUIVALENT TO ORAL DELIVERY | 2018-02-01 |
| 20180028468 | SUSTAINED RELEASE DRUG DELIVERY DEVICES | 2018-02-01 |
| 20180028469 | Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same | 2018-02-01 |
| 20180028470 | CURCUMIN-BASED PHARMACEUTICAL COMPOSITIONS AND METHODS FOR FABRICATING THEREOF | 2018-02-01 |
| 20180028471 | CONTINUOUS LOCAL SLOW-RELEASE OF THERAPEUTICS FOR HEAD AND NECK PROBLEMS AND UPPER AERODIGESTIVE DISORDERS | 2018-02-01 |
| 20180028472 | TAMPER-RESISTANT DOSAGE FORM COMPRISING A POLYETHYLENE GLYCOL GRAFT COPOLYMER | 2018-02-01 |
| 20180028473 | NUTRIENTS SOLUTIONS | 2018-02-01 |
| 20180028474 | METHODS FOR THE BIOSYNTHESIS OF TAURINE OR HYPOTAURINE IN CELLS | 2018-02-01 |
| 20180028475 | COMBINATIONS OF IRS/STAT3 DUAL MODULATORS AND ANTI-CANCER AGENTS FOR TREATING CANCER | 2018-02-01 |
| 20180028476 | STABLE DOSAGE FORMS OF LEVOMILNACIPRAN | 2018-02-01 |
| 20180028477 | TREATMENT OF CARDIAC REMODELING AND OTHER HEART CONDITIONS | 2018-02-01 |
| 20180028478 | ANTIVIRAL COMPOSITIONS DIRECTED AGAINST THE NUCLEOPROTEIN OF INFLUENZA VIRUSES | 2018-02-01 |
| 20180028479 | MEDIUM CHAIN FATTY ACIDS AND THEIR TRIGLYCERIDES FOR TREATING ANXIETY | 2018-02-01 |
| 20180028480 | METHODS OF REDUCING OR PREVENTING OXIDATIVE MODIFICATION OF MEMBRANE POLYUNSATURATED FATTY ACIDS | 2018-02-01 |
| 20180028481 | DENTAL COMPOSITION AND USE | 2018-02-01 |
| 20180028482 | CHLOROGENIC ACID COMPOSITION AND METHOD FOR ITS USE IN THE TREATMENT OF ALZHEIMER'S DISEASE | 2018-02-01 |
| 20180028483 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | 2018-02-01 |
| 20180028484 | Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea | 2018-02-01 |
| 20180028485 | JUICE BEVERAGE FOR PREVENTION AND TREATMENT OF RENAL STONES | 2018-02-01 |
| 20180028486 | DOCETAXEL ALBUMIN NANOPARTICLE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF | 2018-02-01 |
| 20180028487 | DERMATOLOGICAL FORMULATIONS OF 2-(2-ETHOXY-2-OXOETHYL)(METHYL)AMINO-2-OXOETHYL 5-(TETRADECYLOXY)FURAN-2-CARBOXYLATE | 2018-02-01 |
| 20180028488 | TREATING AND/OR PREVENTING INSULIN-RESISTANCE RELATED WEIGHT GAIN | 2018-02-01 |
| 20180028489 | STABLE CANNABINOID FORMULATIONS | 2018-02-01 |
| 20180028490 | Methods Of Treating Diarrhea And Promoting Intestinal Health In Non-Human Animals | 2018-02-01 |
| 20180028491 | METHODS OF DIAGNOSING AND TREATING ALZHEIMER'S DISEASE WITH S-EQUOL | 2018-02-01 |
| 20180028492 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | 2018-02-01 |
| 20180028493 | INHIBITORS OF INDUCED MMP-1 PRODUCTION | 2018-02-01 |
| 20180028494 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFLAMMATORY EAR DISEASES, METHOD FOR PRODUCING SAME AND METHOD FOR TREATMENT USING SAID COMPOSITION | 2018-02-01 |
| 20180028495 | USES OF INDOLINONE COMPOUNDS | 2018-02-01 |
| 20180028496 | COMPOSITION COMPRISING A PHOTOSENSITIVE COMPOUND IN A POLYMERIC NANOPARTICLE, AND A METHOD OF USING THE COMPOSITION | 2018-02-01 |
| 20180028497 | PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA | 2018-02-01 |
| 20180028498 | A PHARMACEUTICAL COMPOSITION FOR THE PARENTERAL ADMINISTRATION OF MELATONIN, AND A PROCESS FOR ITS PREPARATION | 2018-02-01 |
| 20180028499 | 5HT AGONISTS FOR TREATING DISORDERS | 2018-02-01 |
| 20180028500 | New Azabenzimidazole Derivatives as Agonists of the AMP-Activated Protein Kinase | 2018-02-01 |
| 20180028501 | POSITIVE ALLOSTERIC MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 2018-02-01 |
| 20180028502 | N-carbamoylated urethane for treating a neuroinflammatory disease | 2018-02-01 |
| 20180028503 | Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder | 2018-02-01 |
| 20180028504 | Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder | 2018-02-01 |
| 20180028505 | Methods of Preventing Cardiovascular Events in Residual Risk Dyslipidemic Populations | 2018-02-01 |
| 20180028506 | Methods of Preventing the Occurrence of Cardiovascular Events | 2018-02-01 |
| 20180028507 | 3-CARBAMOYLPHENYL-4-CARBOXAMIDE AND ISOPHTALAMIDE DERIVATIVES AS INHIBITORS OF THE WNT SIGNALLING PATHWAY | 2018-02-01 |
| 20180028508 | INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 | 2018-02-01 |
| 20180028509 | SUBSTITUTED QUINOLIZINE DERIVATIVES USEFUL AS HIV INTEGRASE INHIBITORS | 2018-02-01 |
| 20180028510 | PREVENTION AND TREATMENT OF THROMBOSIS IN MEDICALLY ILL PATIENTS | 2018-02-01 |
| 20180028511 | S1P MODULATING AGENTS | 2018-02-01 |
| 20180028512 | DONEPEZIL TRANSDERMAL DELIVERY SYSTEM | 2018-02-01 |
| 20180028513 | METHODS FOR TREATING AN IMPAIRMENT IN GAIT AND/OR BALANCE IN PATIENTS WITH MULTIPLE SCLEROSIS USING AN AMINOPYRIDINE | 2018-02-01 |
| 20180028514 | Compositions and Methods for Treatment of Edema | 2018-02-01 |
| 20180028515 | PYRIDINONE COMPOUND AND USE THEREOF | 2018-02-01 |
| 20180028516 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | 2018-02-01 |
| 20180028517 | BENZIMIDAZOLE SULFIDE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF TUBERCULOSIS | 2018-02-01 |
| 20180028518 | Heterocyclic Compounds and Methods of Use | 2018-02-01 |
| 20180028519 | Use of Flecainide as an Anti-Connexin Agent and Method for Potentiating the Effects of a Psychotropic Drug | 2018-02-01 |
| 20180028520 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS | 2018-02-01 |
| 20180028521 | Methods of Treating Prostate Cancer | 2018-02-01 |
| 20180028522 | QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL INFECTION | 2018-02-01 |
| 20180028523 | ALKALOIDS AND THEIR PREPARATION AND APPLICATION AS ANTI-HSV-1 AGENTS | 2018-02-01 |
| 20180028524 | PREPARATION AND ANTI-HSV-1 APPLICATION OF QUINOLINONE DERIVATIVES | 2018-02-01 |
